Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Liquidia Corp (NASDAQ: LQDA) closed the day trading at $10.02 down -2.39% from the previous closing price of $10.27. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 1.2 million shares were traded. LQDA stock price reached its highest trading level at $10.67 during the session, while it also had its lowest trading level at $9.994.
Ratios:
For a better understanding of LQDA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.33 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On August 16, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $27.Raymond James initiated its Outperform rating on August 16, 2024, with a $27 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 18 ’24 when Saggar Rajeev sold 2,526 shares for $11.19 per share. The transaction valued at 28,266 led to the insider holds 204,857 shares of the business.
Schundler Russell sold 2,576 shares of LQDA for $28,613 on Oct 14 ’24. The General Counsel now owns 486,048 shares after completing the transaction at $11.11 per share. On Oct 14 ’24, another insider, Saggar Rajeev, who serves as the Chief Medical Officer of the company, sold 2,260 shares for $11.11 each. As a result, the insider received 25,103 and left with 207,383 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LQDA now has a Market Capitalization of 848481856 and an Enterprise Value of 772092992. For the stock, the TTM Price-to-Sale (P/S) ratio is 53.47 while its Price-to-Book (P/B) ratio in mrq is 7.67. Its current Enterprise Value per Revenue stands at 52.028 whereas that against EBITDA is -8.056.
Stock Price History:
Over the past 52 weeks, LQDA has reached a high of $16.99, while it has fallen to a 52-week low of $6.10. The 50-Day Moving Average of the stock is -4.55%, while the 200-Day Moving Average is calculated to be -19.10%.
Shares Statistics:
Over the past 3-months, LQDA traded about 1.21M shares per day on average, while over the past 10 days, LQDA traded about 783480 shares per day. A total of 68.63M shares are outstanding, with a floating share count of 58.20M. Insiders hold about 30.09% of the company’s shares, while institutions hold 46.23% stake in the company. Shares short for LQDA as of 1730332800 were 10334276 with a Short Ratio of 8.57, compared to 1727654400 on 11839099. Therefore, it implies a Short% of Shares Outstanding of 10334276 and a Short% of Float of 18.879999.
